FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
FDA Issues Warning Letters to Marketers of Unapproved 'Alternative Hormone Therapies' promoted for treatment or prevention of cancer, heart disease, and osteoporosis
FDA Issues Information for Consumers about Claims for Green Tea and Certain Cancers
Study Finds Additional Evidence for Contamination of Herbal Supplement for Prostate Cancer
FDA Warns Consumers to Stop Using PC SPES and SPES Capsules
Potential Risk of Kava-Containing Dietary Supplements
FDA Advises Dietary Supplement Manufacturers to Remove Comfrey Products From the Market
FDA Issues a Nationwide Alert on the Recall of Thirteen "Treasure of The East" Herbal Products Because of Possible Health Risk
Letter to Health Professionals Regarding Safety Concerns Related to the Use of Botanical Products Containing Aristolochic Acid
Aristolochic Acid - FDA Concerned About Botanical Products, Including Dietary Supplements, Containing Aristolochic Acid
